Biomedical innovators are developing new autoimmune therapeutics - insurance reform will ensure new treatments and cures are accessible and affordable.

YouTube video by BioCentury Video

Wouldn’t it be better if everyone in our ecosystem were candid with one another? After all, within companies it’s common to encourage everyone to speak their minds. If you see a problem, call it out;...

Designed to empower biotech professionals early in their career and set them up to succeed in the broader context in which they operate, this free mini-course is full of everything you've wanted to know about biotech but didn't know who to ask.

The Biden administration’s bird flu response has been too slow. Now comes a test for Trump’s White House.

GRUPPO PROGRESS Da 30 anni mettiamo a tua disposizione l'eccellenza dei software gestionali italiani, accompagnati dall'expertise e dalla competenza dei nostri specialisti certificati. Con la nost...

Your home for biotech and planetary health insight and opinion.

You’ve read one of our articles about why the amount we pay for branded drugs while they’re on patent is worth it, or our calls for insurance reform. But you still have some questions. We hope this an...

Unlike our healthcare spending that goes to services and should be considered an expense, the mere 8% we spend on novel medicines doesn’t just pay for the same things year over year – it’s an investme...